1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. NEXALIN TECHNOLOGY INC
Nexalin Technology Inc
XNAS: NXL
Download real time
0.31 -0.01 (-3.12%)
New 52W Low today
548.5K
XNAS Volume
High volume today

XNAS 19 May, 2026 9:42 AM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Nexalin Tech Inc

The latest disclosure was made by Justin Van Fleet in Nexalin Tech Inc where a trade of 100,000 Stock Option (right to buy)* done was reported to US exchanges on Dec. 19, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Justin Van Fleet CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 100,000 230,435 - - Stock Option (right to buy)*
Carolyn Shelton Sr. VP - Quality - Regulatory Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 100,000 210,620 - - Stock Option (right to buy)*
Alan Kazden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 100,000 362,500 - - Stock Option (right to buy)*
David Owens Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 1,000,000 2,484,809 - - Stock Option (right to buy)*
Benjamin V. Hu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 100,000 100,000 - - Stock Option (right to buy)*
Mark White Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 1,000,000 2,387,024 - - Stock Option (right to buy)*
Alan Kazden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2025 36,459 119,590 - 0 Common stock
David Owens Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2025 36,459 191,252 - 0 Common stock
Benjamin V. Hu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2025 36,459 377,095 - 0 Common stock
Carolyn Shelton Sr. VP - Quality - Regulatory Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2025 20,000 110,620 - - Stock Option (right to buy)
David Owens Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2025 100,000 1,484,809 - - Stock Option (right to buy)
David Owens Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2025 203,125 1,384,809 - - Stock Option (right to buy)
Marilyn Elson Ten Percent Owner 10 Sep 2025 23,150 112,850 - - Common Stock Warrants
Marilyn Elson Ten Percent Owner 17 Jul 2025 30,000 316,000 - - Stock Option (right to buy)
Marilyn Elson Ten Percent Owner 17 Jul 2025 30,000 346,000 - - Stock Option (right to buy)
Marilyn Elson Ten Percent Owner 17 Jul 2025 150,000 286,000 - - Stock Option (right to buy)
Marilyn Elson Ten Percent Owner 17 Jul 2025 30,000 406,000 - - Stock Option (right to buy)
Marilyn Elson Ten Percent Owner 17 Jul 2025 30,000 436,000 - - Stock Option (right to buy)
Marilyn Elson Ten Percent Owner 17 Jul 2025 30,000 376,000 - - Stock Option (right to buy)
Carolyn Shelton Sr. VP - Quality, Regulatory Purchase of securities on an exchange or from another person at price $ 2.20 per share. 12 Mar 2025 6,000 30,000 - 2.2 13,200 Common Stock
David Owens Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 125,000 919,184 - - Stock Option (right to buy)
David Owens Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 654,363 794,184 - - Stock Option (right to buy)
David Owens Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 139,821 139,821 - - Stock Option (right to buy)
Mark White Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 939,597 1,387,024 - - Stock Option (right to buy)
Mark White Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 447,427 447,427 - - Stock Option (right to buy)
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 2.98 per share. 04 Feb 2025 1,000 154,793 - 3.0 2,980 Common stock
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 3.10 per share. 04 Feb 2025 1,000 155,793 - 3.1 3,100 Common stock
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 2.70 per share. 28 Jan 2025 1,500 153,793 - 2.7 4,050 Common stock
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 2.70 per share. 13 Jan 2025 1,000 152,293 - 2.7 2,700 Common stock
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 2.50 per share. 13 Jan 2025 2,000 151,293 - 2.5 5,000 Common stock
Alan Kazden Director 31 Dec 2024 262,500 262,500 - - Stock Option (right to buy)
Carolyn Shelton Senior VP Purchase of securities on an exchange or from another person at price $ 0.85 per share. 31 Dec 2024 24,000 24,000 - 0.9 20,400 Common stock
Carolyn Shelton Senior VP 31 Dec 2024 90,620 90,620 - - Stock Option (right to buy)
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 2.75 per share. 31 Dec 2024 1,000 149,293 - 2.8 2,750 Common stock
David Owens Director, Chief Medical Officer 31 Dec 2024 262,500 262,500 - - Stock Option (right to buy)
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 2.19 per share. 28 Oct 2024 500 148,293 - 2.2 1,095 Common stock
Marilyn Elson Ten Percent Owner 30 Sep 2024 700,000 1,535,244 - 0 Common Stock
Benjamin V. Hue Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 175,000 340,636 - 0 Common stock
Leslie Bernhard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 49,838 49,838 - 0 Common stock
Marilyn Elson Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Sep 2024 700,000 1,535,244 - 0 Common Stock
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.95 per share. 13 Aug 2024 1,000 147,793 - 1.0 950 Common stock
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 1.75 per share. 28 Jun 2024 1,000 146,793 - 1.8 1,750 Common stock
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.71 per share. 18 Jun 2024 1,619 145,793 - 0.7 1,149 Common stock
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.65 per share. 10 Jun 2024 2,000 143,174 - 0.7 1,300 Common stock
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.62 per share. 10 Jun 2024 1,000 144,174 - 0.6 620 Common stock
Marilyn Elson Ms. Elson serves as CFO, Ten Percent Owner 28 Sep 2022 9,500 835,244 - 1.1 10,640 Common Stock
Marilyn Elson Ten Percent Owner 28 Sep 2022 36,000 136,000 - - Common stock warrants
Marilyn Elson Ms. Elson serves as CFO, Ten Percent Owner 16 Sep 2022 36,000 825,744 - 4.2 149,400 Common Stock
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 4.15 per share. 16 Sep 2022 2,500 141,174 - 4.2 10,375 Common Stock
Rick J. Morad Director Purchase of securities on an exchange or from another person at price $ 4.15 per share. 16 Sep 2022 2,500 108,341 - 4.2 10,375 Common Stock
Marilyn Elson Ms. Elson serves as CFO, Ten Percent Owner 16 Sep 2022 100,000 100,000 - - Common stock warrants
Alan Kazden Director Purchase of securities on an exchange or from another person at price $ 4.15 per share. 16 Sep 2022 2,500 83,131 - 4.2 10,375 Common Stock
Mark White Director, President/CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Sep 2022 25,000 25,000 - - Common stock warrants
David Owens Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Sep 2022 2,500 2,500 - - Common stock warrants
Alan Kazden Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Sep 2022 2,500 2,500 - - Common stock warrants
Mark White Director, President/CEO Purchase of securities on an exchange or from another person at price $ 4.15 per share. 15 Sep 2022 25,000 309,127 - 4.2 103,750 Common Stock
Mark White Director, President/CEO Purchase of securities on an exchange or from another person at price $ 4.15 per share. 15 Sep 2022 25,000 289,627 - 4.2 103,750 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters